Curriculum Vitae

PERSONAL DETAILS

DR. TEO SOO HWANG


ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • MASTER DEGREE, ARTS, CAMBRIDGE UNIVERSITY, UK
  • Doctoral Degree (PhD), BIOCHEMISTRY, CAMBRIDGE UNIVERSITY, UK
  • Bachelor Degree, ARTS, CAMBRIDGE UNIVERSITY, UK
PUBLICATIONS
(Title of publication in APA style)
Refereed Journals
2016
  • Wen WX, Soo JS, Kwan PY, Hong E, Khang TF, Mariapun S, Lee CS, Hasan SN, Rajadurai P, Yip CH, Mohd Taib NA, Teo SH.Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation. (WoS)
  • Bhoo-Pathy N1,2, Balakrishnan N3, See MH3, Taib NA3, Yip CH3. 2016 . Missed Opportunities for Loco-Regional Treatment of Elderly Women with Breast Cancer.World J Surg. 2016 Jul 25. [Epub ahead of print] (WoS)
  • Horne HN, Chung CC, Zhang H, Yu K, Prokunina-Olsson L, Michailidou K, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, Lophatananon A, Fasching PA, Beckmann MW, Fletcher O, Johnson N, Sawyer EJ, Tomlinson I, Burwinkel B, Marme F, Gu nel P, Truong T, Bojesen SE, Flyger H, Benitez J, Gonz lez-Neira A, Anton-Culver H, Neuhausen SL, Brenner H, Arndt V, Meindl A, Schmutzler RK, Brauch H, Hamann U, Nevanlinna H, Khan S, Matsuo K, Iwata H, D rk T, Bogdanova NV, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Chenevix-Trench G; kConFab/AOCS Investigators, Wu AH, Ven den Berg D, Smeets A, Zhao H, Chang-Claude J, Rudolph A, Radice P, Barile M, Couch FJ, Vachon C, Giles GG, Milne RL, Haiman CA, Marchand LL, Goldberg MS, Teo SH, Taib NA, Kristensen V, Borresen-Dale AL, Zheng W, Shrubsole M, Winqvist R, Jukkola-Vuorinen A, Andrulis IL, Knight JA, Devilee P, Seynaeve C, Garc a-Closas M, Czene K, Darabi H, Hollestelle A, Martens JW, Li J, Lu W, Shu XO, Cox A, Cross SS, Blot W, Cai Q, Shah M, Luccarini C, Baynes C, Harrington P, Kang D, Choi JY, Hartman M, Chia KS, Kabisch M, Torres D, Jakubowska A, Lubinski J, Sangrajrang S, Brennan P, Slager S, Yannoukakos D, Shen CY, Hou MF, Swerdlow A, Orr N, Simard J, Hall P, Pharoah PD, Easton DF, Chanock SJ, Dunning AM, Figueroa JD. 2016. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.PLoS One 11(8):e0160316. doi: 10.1371/journal.pone.0160316. (WoS/SCOPUS)
  • Ng PS1, Wen WX2, Fadlullah MZ3, Yoon SY4, Lee SY5, Thong MK6, Yip CH7, Mohd Taib NA8,9, Teo SH . 2016. Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing. Clin Genet. doi: 10.1111/cge.12735. (WoS)
2015
  • Kang PC, Phuah SY, Sivanandan K, Kang IN, Thirthagiri E, Liu JJ, Hassan N, Yoon SY, Thong MK, Hui M, Hartman M, Yip CH, Taib NA, Teo SH.2015.Erratum to: Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.Breast Cancer Res Treat.150(3):699- 700. (WoS)
  • Narayanan V, Taib NA,Teo SH.Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance. J Pathol. 2015 Jul 14. doi: 10.1002/path.4583. (WoS)
2014
  • Jingmei Li,Linda S. Lindstr m,Jia N. Foo,Marjanka K. Schmidt,Paul D. P. Pharoah,Kyriaki Michailidou,Manjeet K. Bolla,Qin Wang,Laura J. Van t Veer,Sten Cornelissen,Emiel Rutgers, Melissa C. Southey,Carmel Apicella,Gillian S. Dite,John L. Hopper,Peter A. Fasching,Lothar Haeberle,Arif B. Ekici,Matthias W. Beckmann,Carl Blomqvist,Taru A. Muranen,Kristiina Aittom , Annika Lindblom,Sara Margolin,Arto Mannermaa,Veli-Matti Kosma,Jaana M. Hartikainen,Vesa Kataja,Georgia Chenevix-Trench,kConFab Investigators,Kelly-Anne Phillips,Sue-Anne McLachlan, Diether Lambrechts,Bernard Thienpont,Ann Smeets,Hans Wildiers,Jenny Chang-Claude,Dieter Flesch-Janys,Petra Seibold,Anja Rudolph,Graham G. Giles,Laura Baglietto,Gianluca Severi, Christopher A. Haiman,Brian E. Henderson,Fredrick Schumacher,Loic Le Marchand,Vessela Kristensen,Grethe I. Grenaker Aln Anne-Lise Borresen-Dale,Silje Nord,Robert Winqvist, Katri Pylk Arja Jukkola-Vuorinen,Mervi Grip,Irene L. Andrulis,Julia A. Knight,Gord Glendon,Sandrine Tchatchou,Peter Devilee,Robert Tollenaar,Caroline Seynaeve,Maartje Hooning, Mieke Kriege,Antoinette Hollestelle,Ans van den Ouweland,Yi Li,Ute Hamann,Diana Torres,Hans U. Ulmer,Thomas R diger,Chen-Yang Shen,Chia-Ni Hsiung,Pei-Ei Wu,Shou-Tung Chen, Soo Hwang Teo,Nur Aishah Mohd Taib,Cheng Har Yip,Gwo Fuang Ho,Keitaro Matsuo,Hidemi Ito,Hiroji Iwata,Kazuo Tajima,Daehee Kang,Ji-Yeob Choi,Sue K. Park,Keun-Young Yoo,Tom Maishman, William J. Tapper,Alison Dunning,Mitul Shah,Robert Luben,Judith Brown,Chiea Chuen Khor,Diana M. Eccles,Heli Nevanlinna,Douglas Easton,Keith Humphreys,Jianjun Liu,Per Hall & Kamila Czene. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Nature Communications 5: 4051 (WoS/SCOPUS)
2013
  • Prevalence of PALB2 mutations in breast cancer patients in multi- ethnic Asian population in Malaysia and Singapore. Phuah SY, Lee SY, Kang P, Kang IN, Yoon SY, Thong MK, Hartman M, Sng JH,YipCH,Mohd Taib NA, TeoSH. Plos One2013 (WoS)
  • Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, Choi JY, Long J, Dennis J, Humphreys MK, Wang Q, Lu W, Gao YT, Li C, Cai H, Park SK, Yoo KY, Noh DY, Han W, Dunning AM, Benitez J, Vincent D, Bacot F, Tessier D, Kim SW, Lee MH, Lee JW, Lee JY, Xiang YB, Zheng Y, Wang W, Ji BT, Matsuo K, Ito H, Iwata H, Tanaka H, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Teo SH, Yip CH, Kang IN, Wong TY, Shen CY, Yu JC, Huang CS, Hou MF, Hartman M, Miao H, Lee SC, Putti TC, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Sangrajrang S, Shen H, Chen K, Wu PE, Ren Z, Haiman CA, Sueta A, Kim MK, Khoo US, Iwasaki M, Pharoah PD, Wen W, Hall P, Shu XO, Easton DF, Kang D. Hum Mol Genet. 2013 Mar 27. [Epub ahead of print] (WoS)
2012
  • Triple negative breast cancer and phosphatase and tensin homolog loss are predictors of BRCA1 germline mutations in women with early onset and familial breast cancer, but not in women with isolated late- onset breast cancer. Phuah SY, Looi LM, Hassan N, Rhodes A, Dean S, Mohd Taib NA, Yip CH, Teo SH. Breast Cancer Res. (2012) Nov 2;14(6):R142. (WoS)
  • Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Laitman Y, Feng BJ, Zamir IM, Weitzel JN, Duncan P, Port D, Thirthagiri E, Teo SH, Evans G, Latif A, Newman WG, Gershoni-Baruch R, Zidan J, Shimon-Paluch S, Goldgar D, Friedman E. Eur J Hum Genet. (2012) Jul 4. doi: 10.1038/ejhg.2012.124. (WoS)
  • Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Res. 2012 Apr 16;14(2):R61. (WoS/SCOPUS)
2011
  • Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Yoon SY, Thong MK, Taib NA, Yip CH, Teo SH. Fam Cancer. (2011) Feb 12. (WoS)
  • Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. A Mitra, EK. Bancroft, Y Barbachano, EC. Page, CS Foster, C Jameson, G. Mitchell, GJ Lindeman, A. Stapleton, G. Suthers, DG Evans, D Cruger, I Blanco, C Mercer, J Kirk, L Maehle, S Hodgson, L Walker, L Izatt, F Douglas, K Tucker, H Dorkins, V Clowes, A Male, A Donaldson, C Brewer, R Doherty, B Bulman, PJ Osther, M Salinas, D Eccles, K Axcrona, I Jobson, B Newcombe, C Cybulski, WS Rubinstein, S Buys, S Townshend, E Friedman, S Domchek, T Ramony Cajal, A. Spigelman, SH Teo, N Nicolai, N Aaronson, A Ardern-Jones, C Bangma, D Dearnaley, J Eyfjord, A Falconer, H Gr nberg, F. Hamdy, O. Johannsson, V. Khoo, Z. Kote-Jarai, H. Lilja, J. Lubinski, J. Melia, C. Moynihan, S. Peock, G. Rennert, F. Schr der, P. Sibley, M. Suri, P. Wilson, Y. J. Bignon, S. Strom, M. Tischkowitz, A. Liljegren, D. Ilencikova, A. Abele, K. Kyriacou, C. van Asperen, L. Kiemeney, The IMPACT Study Collaborators, D. F. Easton and R Eeles BJU Int. (2011) 107(1):28-39 (WoS)
2010
  • Large genomic rearrangements in BRCA1 and BRCA2 in Malaysian Breast Cancer Patients. Kang P, S Mariapun, Phuah SY, Lim LL, Liu JJ, Yoon SY, Thong MK, NA Mohd Taib, Yip CH and Teo SH Breast Cancer Res Treatment (2010) 124(2):579-84 (WoS)
2009
  • Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country. Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH. World J Surg. (2009) 33: 2077 - 81 (WoS)
  • Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country. Tan GH, Taib NA, Choo WY, Teo SH, Yip CH. Asian Pac J Cancer Prev. (2009) 10(3):395-8. (WoS)
  • CHEK2 1100delC does not contribute significantly to breast cancer risk in Malaysia s multi-ethnic population. E Thirthagiri, Cheong LS, CH Yip and SH Teo Familial Cancer (2009) 8(4): 355-8 (WoS)
2008
  • Evaluation of BRCA1 and BRCA2 mutations and risk prediction models in a typical Asian country (Malaysia) with relatively low incidence of breast cancer. E Thirthagiri, SY Lee, P Kang, D Lee, GT Toh, SA Selamat, SY Yoon, NA Taib, MK Thong, CH Yip, and SH Teo. Breast Cancer Research (2008) 10 R59 (WoS)
  • BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. GT Toh, P Kang, SS Lee, DS Lee, SY Lee, SA Selamat, NA Taib, SY Yoon, CH Yip and SH Teo. PlosOne (2008) 3(4) e2024 (WoS)